Abstract:

Macular edema is one of main reason that lead to visual loss and poor visual prognosis of patients with retinal vein occlusion. Current treatment options for macular edema include grid laser treatment, intravitreal injection of steroids, surgical procedures and intravitreal anti-vascular endothelial growth factor (VEGF) agents. Anti-VEGF agents have been wide used in the treatment of various forms of macular edema, due to their reliable effect and less complications. However, repeatedly treatment and recurrence of macular edema have not been resolved. Individual treatment and combination therapy provide new ideas for reducing the cost of medical treatment for macular edema.  (Int Rev Ophthalmol, 2016, 40: 289-294)